OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,999 | -87.6% | 8,280 | -79.2% | 0.00% | -100.0% |
Q1 2023 | $209,440 | +238.9% | 39,742 | +80.7% | 0.00% | – |
Q4 2022 | $61,798 | -60.4% | 21,992 | -41.6% | 0.00% | – |
Q3 2022 | $156,000 | +225.0% | 37,689 | +214.9% | 0.00% | – |
Q2 2022 | $48,000 | +860.0% | 11,970 | +1031.4% | 0.00% | – |
Q1 2022 | $5,000 | -98.8% | 1,058 | -97.5% | 0.00% | – |
Q3 2021 | $425,000 | -63.8% | 42,495 | -48.6% | 0.00% | -100.0% |
Q2 2021 | $1,173,000 | +41.0% | 82,727 | +63.3% | 0.00% | 0.0% |
Q1 2021 | $832,000 | -36.6% | 50,675 | -20.1% | 0.00% | -50.0% |
Q4 2020 | $1,313,000 | +976.2% | 63,431 | +295.9% | 0.00% | – |
Q3 2020 | $122,000 | +713.3% | 16,023 | +226.5% | 0.00% | – |
Q3 2019 | $15,000 | -65.1% | 4,907 | -54.7% | 0.00% | – |
Q4 2018 | $43,000 | -64.5% | 10,827 | -38.4% | 0.00% | -100.0% |
Q3 2018 | $121,000 | +476.2% | 17,572 | +275.1% | 0.00% | – |
Q4 2017 | $21,000 | -30.0% | 4,684 | -3.5% | 0.00% | – |
Q3 2017 | $30,000 | -37.5% | 4,854 | -5.9% | 0.00% | -100.0% |
Q1 2017 | $48,000 | +37.1% | 5,160 | +22.7% | 0.00% | – |
Q4 2016 | $35,000 | -23.9% | 4,205 | -37.6% | 0.00% | – |
Q3 2016 | $46,000 | +70.4% | 6,742 | +250.6% | 0.00% | – |
Q3 2015 | $27,000 | – | 1,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
Covestor Ltd | 60,008 | $316 | 0.28% |
Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |